Kings Path Partners’s Mesa Laboratories MLAB Stock Holding History

Kings Path Partners’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$242K	Sell	2,433 -972	-29%	-$97.8K	0.06%	106
2026 Q1	$267K	Hold	3,405	–	–	0.09%	94
2025 Q4	$267K	Hold	3,405	–	–	0.09%	94
2025 Q3	$228K	Hold	3,405	–	–	0.08%	95
2025 Q2	$321K	Sell	3,405 -756	-18%	-$83K	0.13%	80
2025 Q1	$494K	Sell	4,161 -2,615	-39%	-$356K	0.24%	55
2024 Q4	$894K	Hold	6,776	–	–	0.38%	68
2024 Q3	$880K	Hold	6,776	–	–	0.37%	70
2024 Q2	$588K	Buy	+6,776	New	+$710K	0.28%	89

Other funds holding MLAB

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

HNB

Hilltop National Bank Casper, Wyoming $468M AUM 36.09% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Kings Path Partners's MLAB Position: Q2 2026 in Review

Kings Path Partners reduced its Mesa Laboratories (MLAB) stake by 29% in Q2 2026, selling an estimated $97.8K and leaving 2,433 shares worth $242K. The position accounts for 0.06% of the portfolio, ranked #106.

Kings Path Partners first reported a position in MLAB in Q2 2024 and has held it in 9 quarters since. The position peaked at $894K in Q4 2024. 12 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Kings Path Partners held 2,433 shares of Mesa Laboratories worth $242K as of Q2 2026.
Kings Path Partners sold 972 Mesa Laboratories shares in Q2 2026, an estimated $97.8K.
Mesa Laboratories made up 0.06% of Kings Path Partners's portfolio in Q2 2026, its #106 holding.
Kings Path Partners first reported a position in Mesa Laboratories in Q2 2024 and has held it in 9 quarters since.
Kings Path Partners's Mesa Laboratories position peaked at $894K in Q4 2024.
12 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Kings Path Partners's 13F filing for Q2 2026, filed 14 Jul 2026.